mRNA Adjuvant Boosts Immunity, Colossal Biosciences Sparks Skepticism Over Egg Tech, Pediatric Dexmedetomidine Boosts Cognition, FSU Breakthrough Synthesizes Marine Compounds, and more... episode artwork

EPISODE · May 20, 2026 · 11 MIN

mRNA Adjuvant Boosts Immunity, Colossal Biosciences Sparks Skepticism Over Egg Tech, Pediatric Dexmedetomidine Boosts Cognition, FSU Breakthrough Synthesizes Marine Compounds, and more...

from Science News Daily · host brief.news

(0:10): Breakthrough mRNA Adjuvant Boosts T-Cell Responses, Shows Promise for Cancer Immunotherapy and Infectious Disease Vaccines(2:36): Colossal Biosciences' Moa Revival: Artificial Egg Technology Sparks Skepticism Despite Engineering Feats(4:29): Study Reveals Pediatric Sedation with Dexmedetomidine Linked to Better Long-Term Cognitive Outcomes(6:34): FSU Achieves Breakthrough in Synthesizing Marine Compounds for Cancer Drug Development(9:00): Glycan Atlasing Offers Breakthrough in Early Disease Detection and Diagnosis Through Sugar MappingTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Time

Episode metadata supplied by the publisher feed · Published May 20, 2026

Embed this episode

Ready to play

mRNA Adjuvant Boosts Immunity, Colossal Biosciences Sparks Skepticism Over Egg Tech, Pediatric Dexmedetomidine Boosts Cognition, FSU Breakthrough Synthesizes Marine Compounds, and more...

0:00 11:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science News Daily?

This episode is 11 minutes long.

When was this Science News Daily episode published?

This episode was published on May 20, 2026.

Can I download this Science News Daily episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!